Improving radio-chemotherapy efficacy of prostate cancer by co-deliverying docetaxel and dbait with biodegradable nanoparticles
Nianli Liu(Xuzhou Medical College), Longzhen Zhang(Jiangsu University), Hong Yao(Xuzhou Medical College), Senbang Yao(Anhui Medical University), Zhiying Shao(Xuzhou Medical College), Jiayin Ji(China Aerospace Science and Industry Corporation (China)), Xin Wen(Xuzhou Medical College), Hui Qiu(Xuzhou Medical College), Aoxing Chen(Xuzhou Medical College), Xingying Zhang(Xuzhou Medical College)
Cited by 17
Related Papers
Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study
|Journal of Clinical Oncology|2022|306
The Impact of VR-CALM Intervention Based on VR on Psychological Distress and Symptom Management in Breast Cancer Survivors
|Journal of Oncology|2022|45
Depression in breast cancer patients: Immunopathogenesis and immunotherapy
|Cancer Letters|2022|43
Development of a machine learning-based model to predict prognosis of alpha-fetoprotein-positive hepatocellular carcinoma
|Journal of Translational Medicine|2024|26